ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,711.95
      0.16%
      US Tech 100
      19,353.60
      0.29%
      Dow Jones
      42,067.29
      0.01%
      Brent Oil
      73.755
      -0.18%
      Bitcoin
      63,151.98
      -0.74%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Bicycle Therapeutics PLC (BCYC) Quote

      Bicycle Therapeutics PLC

      Bicycle Therapeutics PLC (BCYC)

      NASDAQ
      24.5089
      -0.9011
      ( -3.55% )
      Updated: 10:53:24
      Delayed by 15 minutes

      Empower your portfolio: Real-time discussions and actionable trading ideas.

      Premium

      Key stats and details

      Current Price
      24.5089
      Bid
      24.51
      Ask
      24.64
      Volume
      27,579
      24.5089 Day's Range 25.515
      0.00 52 Week Range 0.00
      Market Cap
      1.691B
      Previous Close
      25.41
      Open
      25.41
      Last Trade
      9
      @
      24.57
      Last Trade Time
      10:53:24
      Financial Volume
      $ 690,650
      VWAP
      25.0426
      Average Volume (3m)
      -
      Shares Outstanding
      68,993,458
      Dividend Yield
      -
      PE Ratio
      -9.54
      Earnings Per Share (EPS)
      -2.62
      Revenue
      26.98M
      Net Profit
      -180.66M

      About Bicycle Therapeutics PLC

      Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops which stabilize their structural geometry. Its initial internal programs are focused... Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops which stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical need. Show more

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      www.bicycletherapeutics.com
      Headquarters
      Cambridge, Gbr
      Founded
      -
      Bicycle Therapeutics PLC is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker BCYC. The last closing price for Bicycle Therapeutics was $25.41. Over the last year, Bicycle Therapeutics shares have traded in a share price range of $ 0.00 to $ 0.00.

      Bicycle Therapeutics currently has 68,993,458 shares outstanding. The market capitalization of Bicycle Therapeutics is $1.75 billion. Bicycle Therapeutics has a price to earnings ratio (PE ratio) of -9.54.

      Ask ADVFN Intelligence (AI)

      Bicycle Therapeutics (BCYC) Options Flow Summary

      BCYC Options Flow

      Overall Flow

      Bullish

      Net Premium

      63k

      Calls / Puts

      100.00%

      Buys / Sells

      100.00%

      OTM / ITM

      0.00%

      Sweeps Ratio

      0.00%

      BCYC Latest News

      More News

      Form 8-K - Current report

      September 19 2024
      Edgar (US Regulatory)

      Bicycle Therapeutics Presents Updated Clinical Results Across Oncology Pipeline at ESMO Congress 2024

      Updated monotherapy data for Nectin-4 targeting zelenectide pevedotin in metastatic urothelial cancer (mUC) showed a promising 45% overall response rate (ORR), 11.1 months median duration of...

      September 14 2024
      Business Wire

      Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

      Bicycle Therapeutics plc (NASDAQ: BCYC), today announced that on September 3, 2024, the Compensation Committee of the company’s Board of Directors granted to seven new employees inducement awards...

      September 03 2024
      Business Wire

      Bicycle Therapeutics to Participate in Upcoming Investor Conferences

      Bicycle Therapeutics plc (NASDAQ: BCYC), a pharmaceutical company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle®) technology, today...

      August 21 2024
      Business Wire

      Form S-8 - Securities to be offered to employees in employee benefit plans

      August 06 2024
      Edgar (US Regulatory)

      Form 10-Q - Quarterly report [Sections 13 or 15(d)]

      August 06 2024
      Edgar (US Regulatory)

      Form 8-K - Current report

      August 06 2024
      Edgar (US Regulatory)

      Bicycle Therapeutics Reports Recent Business Progress and Second Quarter 2024 Financial Results

      Four abstracts containing data updates across clinical pipeline accepted for poster presentation at ESMO Congress 2024 Focused R&D pipeline on clinical programs and research areas that have...

      August 06 2024
      Business Wire

      Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

      Bicycle Therapeutics plc (NASDAQ: BCYC) today announced that on August 1, 2024, the Compensation Committee of the company’s Board of Directors granted to seven new employees inducement awards...

      August 01 2024
      Business Wire

      Bicycle Therapeutics Announces Four Abstracts Accepted for Presentation at the ESMO Congress 2024

      Bicycle Therapeutics plc (NASDAQ: BCYC), a pharmaceutical company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle®) technology, today...

      July 22 2024
      Business Wire
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10000000DR
      40000000DR
      120000000DR
      260000000DR
      520000000DR
      1560000000DR
      2600000000DR

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      KAVLKaival Brands Innovations Group Inc
      $ 1.4501
      (150.45%)
      		89.36M
      TGLTreasure Global Inc
      $ 1.4201
      (108.75%)
      		95.92M
      NVVENuvve Holding Corporation
      $ 6.3174
      (61.16%)
      		24.66M
      UXINUxin Ltd
      $ 2.11
      (33.12%)
      		2.16M
      XPONExpion360 Inc
      $ 0.1091
      (28.66%)
      		287.78M
      ELABElevai Labs Inc
      $ 0.108
      (-61.43%)
      		8.84M
      ADTXAditxt Inc
      $ 0.265
      (-30.74%)
      		1.3M
      ZJYLJin Medical International Ltd
      $ 2.85
      (-30.15%)
      		529.15k
      FRGTFreight Technologies Inc
      $ 0.0813
      (-28.56%)
      		17.34M
      PRFXPainReform Ltd
      $ 0.5995
      (-22.25%)
      		250.93k
      XPONExpion360 Inc
      $ 0.1083
      (27.71%)
      		287.79M
      TGLTreasure Global Inc
      $ 1.425
      (109.47%)
      		95.93M
      KAVLKaival Brands Innovations Group Inc
      $ 1.46
      (152.16%)
      		89.43M
      INTCIntel Corporation
      $ 22.4097
      (2.61%)
      		76.75M
      NVDANVIDIA Corporation
      $ 115.42
      (-0.50%)
      		69.32M

      BCYC Discussion

      View Posts
      Monksdream Monksdream 1 week ago
      BCYC breaking out of a channel
      👍️0
      dhbuzz dhbuzz 2 years ago
      STRONG.......As the move back to where this stock should be. continues.
      👍️0
      dhbuzz dhbuzz 2 years ago
      Good week,should continue gaining.Watching for another pharma .to enter
      perhaps do what Genetech is doing with us now.

      GLTA
      👍️0
      dhbuzz dhbuzz 2 years ago
      Lot of up side potential here at the current SP.

      GLTA
      👍️0

      Your Recent History

      NASDAQ
      BCYC
      Bicycle Therapeutics
      Delayed Upgrade Clock